Company / Operating Income
TENAX THERAPEUTICS, INC. Operating Income History
FY2012-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income
-$19.5M
FY2025
5-year range
-$19.5M / -$5.2M
FY2021-FY2025
Trend
-136.8%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Operating Income has fluctuated over the past 7 years, ranging from -$19M in FY2025 to $11M in FY2012.
Based on SEC 10-K filings.
-$19M in FY2025.
Declined from -$17M to -$19M over the past 9 years.
Operating Income over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, operating income decreased 136.8% year-over-year.
- Peak operating income was recorded in FY2012.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 3.24 (safe zone, above 2.9 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$19.5M | -136.8% |
| FY2024 | -$8.2M | +50.4% |
| FY2016 | -$16.6M | +0.0% |
| FY2015 | -$16.6M | -220.1% |
| FY2014 | -$5.2M | +36.9% |
| FY2013 | -$8.2M | -177.8% |
| FY2012 | $10.6M | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026